OpenAI researcher Miles Wang is in talks to launch an AI drug discovery startup valued at $2 billion, with Lightspeed leading the round.
Take: AI drug discovery is hot again, but at the end of the day, it's about whether the drugs work. Storytelling alone won't cut it.